1. The detection, quantification and partial characterisation of cathepsin B-like activity in human pathological synovial fluids.
- Author
-
Duffy JM, Walker B, Guthrie D, Grimshaw J, McNally G, Grimshaw JT, Spedding PL, and Mollan RA
- Subjects
- Affinity Labels, Blotting, Western, Cathepsin B chemistry, Electrophoresis, Polyacrylamide Gel, Enzyme Activation, Humans, Molecular Weight, Pepsin A pharmacology, Spectrometry, Fluorescence, Arthritis, Rheumatoid enzymology, Cathepsin B metabolism, Osteoarthritis enzymology, Synovial Fluid enzymology
- Abstract
In this study, the levels of the cysteine proteinase--cathepsin B were measured in diseased synovial fluids using a steady state fluorometric assay. Cathepsin B-like activity was shown to be present in all the samples analysed, with the rheumatoid arthritic synovial fluids possessing significantly higher concentrations (mean value ca. 416 mg/l) than the osteoarthritic fluids (mean value ca. 142.4 mg/l). In addition, upon treatment with pepsin, all of the rheumatoid arthritis samples were shown to possess additional cathepsin B-like activity, suggesting the presence of a reservoir of latent precursor molecules. By utilising a recently developed biotinylated affinity label for cathepsin B-like proteinases and sheep anti-(human cathepsin B) antibodies, used in combination with SDS-PAGE and Western blotting, the rheumatoid arthritic synovial cathepsin B was shown to exist in two forms with apparent molecular masses of M(r) 29,000 and 42,000. We propose that the former is a functionally active proteinase, whereas the latter is a pepsin activatable proform which, when cleaved by this aspartyl proteinase, is converted into a catalytically competent species of M(r) 20,000.
- Published
- 1994
- Full Text
- View/download PDF